首页> 外文会议>Conference on Ophthalmic Technologies >A new approach to evaluating the effects of Pharmacologic Vitreolysis on Vitreous diffusion coefficients using dynamic light scattering
【24h】

A new approach to evaluating the effects of Pharmacologic Vitreolysis on Vitreous diffusion coefficients using dynamic light scattering

机译:一种新方法来评价药物玻璃体效果对玻璃散射系数的影响使用动态光散射

获取原文
获取外文期刊封面目录资料

摘要

PURPOSE: Pharmacologic vitreolysis is a new approach to improve vitreo-retinal surgery. Ultimately, the development of drugs to liquefy and detach vitreous from retina should prevent disease by mitigating the contribution of vitreous to retinopathy and eliminate the need for surgery. However, the mechanism of action of pharmacologic vitreolysis remains unclear. The technique of Dynamic light scattering (DLS) was used to evaluate the effects of microplasmin by following the diffusion coefficients of spherical polystyrene nano-particles injected with microplasmin into the vitreous. METHODS: Diffusion coefficients in dissected (n=9) porcine eyes were measured in vitro. DLS was performed on all specimens at 37°C as often as every 10 minutes for up to 6 hours following injections of human recombinant microplasmin at doses ranging from 0.125 mg to 0.8 mg, with 20 nm diameter tracer nanospheres. RESULTS: DLS findings in untreated porcine vitreous were similar to the previously described findings in bovine and human vitreous, demonstrating a fast (early) component, resulting from the flexible hyaluronan molecules, and a slow (late) component, resulting form the stiff collagen molecules. Microplasmin increased porcine vitreous diffusion coefficients. A new approach was developed to use DLS measurements of vitreous diffusion coefficients to evaluate the effects of microplasmin in intact eyes. CONCLUSIONS: Pharmacologic vitreolysis with human recombinant microplasmin increases vitreous diffusion coefficients in vitro. The results of these studies indicate that this new approach using DLS to measure vitreous diffusion coefficients can be used to study the effects of pharmacologic vitreolysis using microplasmin and other agents in intact eyes and ultimately in vivo .
机译:目的:药理玻璃体溶解是一种改善玻璃体视网膜手术的新方法。最终,通过减轻玻璃体对视网膜病变的贡献,从视网膜液化和分离玻璃体的液化和分离玻璃体的液化和分离疾病,消除了对手术的需求。然而,药理玻璃体脱盐的作用机制仍不清楚。动态光散射(DLS)的技术用于通过遵循用微量模粒注入玻璃体的球形聚苯乙烯纳米颗粒的扩散系数来评估微压蛋白的影响。方法:在体外测量解剖的扩散系数(n = 9)猪眼。在37°C的所有样品上以每10分钟的所有样品进行DLS,在注射0.125mg至0.8mg的剂量的人的重组微粒后,每10分钟每10分钟进行6小时,用20nm直径的示踪纳米球。结果:未处理的猪玻璃中的DLS发现类似于牛和人体玻璃体中的先前描述的发现,展示了一种快速(早期)的组分,由柔性透明质酸分子和缓慢(晚)成分,产生抗胶原分子。微药物增加了猪玻璃玻璃杂散系数。开发了一种新方法,用于使用DLS测量玻璃体扩散系数,以评估微压蛋白在完整的眼中的影响。结论:用人重组微药物的药理学玻璃体分解增加了体外玻璃体扩散系数。这些研究的结果表明,这种使用DLS测量玻璃体扩散系数的新方法可用于研究药物玻璃体和其他药物在完整的眼中和最终体内的其他药物的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号